6533b854fe1ef96bd12ae218
RESEARCH PRODUCT
Metabolic classification and intervention opportunities for tumor energy dysfunction
Tomás ÁLvaro NaranjoTomás ÁLvaro NaranjoEzequiel MonferrerEzequiel MonferrerIsaac Vieco-martíFernando FariñasRosa NogueraRosa NogueraAmparo López-carrascoAmparo López-carrascoLuis De La Cruz-merinoSergio Abanadessubject
0301 basic medicineEndocrinology Diabetes and MetabolismMetabolic reprogrammingReviewBiologyBioinformaticsBiochemistryMicrobiology03 medical and health sciences0302 clinical medicinetumor reprogrammingmedicinetumor microenvironmentMolecular BiologyTumor ecosystemTumor reprogrammingTumor microenvironmentCancerCommon denominatorMetabolismHypoxia (medical)medicine.diseaseQR1-502Metabolic pathway030104 developmental biologyCell metabolismTumor microenvironment030220 oncology & carcinogenesistumor ecosystemmedicine.symptomdescription
A comprehensive view of cell metabolism provides a new vision of cancer, conceptualized as tissue with cellular-altered metabolism and energetic dysfunction, which can shed light on pathophysiological mechanisms. Cancer is now considered a heterogeneous ecosystem, formed by tumor cells and the microenvironment, which is molecularly, phenotypically, and metabolically reprogrammable. A wealth of evidence confirms metabolic reprogramming activity as the minimum common denominator of cancer, grouping together a wide variety of aberrations that can affect any of the different metabolic pathways involved in cell physiology. This forms the basis for a new proposed classification of cancer according to the altered metabolic pathway(s) and degree of energy dysfunction. Enhanced understanding of the metabolic reprogramming pathways of fatty acids, amino acids, carbohydrates, hypoxia, and acidosis can bring about new therapeutic intervention possibilities from a metabolic perspective of cancer. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. Asociacion Fundacion Espanola contra el Cancer, JAP-AECC, 2018/150 CIBERONC, CB16/12/00484 FEDER (European Regional Development Fund), PI20/01107 ISCIII (FIS), PI20/01107 NEN Association (Nico contra el cancer infantil), 2017-PVR00157 Neuroblastoma Foundation, PVR00166
year | journal | country | edition | language |
---|---|---|---|---|
2021-04-01 |